All posts by: Michael Zand

About Michael Zand

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA – Streetwise Reports

Continue reading

2017-12-27 NEWS

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA
Streetwise Reports
Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA Research Report. Source: Streetwise Reports (12/27/17). Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech’s device to be used in patients

Continue reading

2017-12-27 NEWS

Impact of Immunotherapy in Advanced Bladder Cancer
OncLive
Daniel J. George, MD: Historically, bladder cancer has been one of the most difficult cancers to treat among the solid tumors in oncology for a long time. This is a patient population that’s pretty sick. Many of these patients are diagnosed later in